VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
GBLIGlobal Indemnity Group, LLC
$25.34$364M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

GBLI logoGlobal Indemnity Group, LLC(GBLI)Earnings, Financials & Key Ratios

GBLI•NASDAQ•Insurance & Managed Care
14.5× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryProperty & Casualty InsuranceSub-IndustryReinsurers and hybrid reinsurance groups
AboutGlobal Indemnity Group, LLC, through its subsidiaries, provides specialty property and casualty insurance and reinsurance products worldwide. It operates through Commercial Specialty; Farm, Ranch, & Stable; and Reinsurance Operations segments. The Commercial Specialty segment distributes property, general liability, casualty, and professional lines products. This segment sells its products through a network of wholesale general agents and program administrators. The Farm, Ranch, & Stable segment offers commercial farm auto and excess/umbrella coverage for the agriculture industry, as well as specialized insurance products for the equine mortality and equine major medical industry on an admitted basis through wholesalers and retail agents. The Reinsurance Operations segment provides offer third-party treaty reinsurance for casualty insurance and reinsurance companies, as well as professional liability products to companies through brokers. Global Indemnity Group, LLC was founded in 2003 and is headquartered in Bala Cynwyd, Pennsylvania.Show more
  • Revenue$450M+2.0%
  • Combined Ratio92.6%+5.8%
  • Net Income$25M-41.4%
  • Return on Equity3.63%-43.8%
  • Medical Cost Ratio50.72%-37.9%
  • Operating Margin7.4%-40.6%
  • Net Margin5.63%-42.6%
  • ROA1.47%-41.3%
  • Equity / Assets41.06%+3.2%

GBLI Key Insights

Global Indemnity Group, LLC (GBLI) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Profitable underwriting: 92.6% combined ratio
  • ✓Low loss ratio of 50.7%
  • ✓Healthy dividend yield of 5.5%
  • ✓Trading at only 0.5x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 4.7%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when GBLI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

GBLI Price & Volume

Global Indemnity Group, LLC (GBLI) stock price & volume — 10-year historical chart

Loading chart...

GBLI Growth Metrics

Global Indemnity Group, LLC (GBLI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-1.78%
5 Years-5.06%
3 Years-10.53%
TTM2.99%

Profit CAGR

10 Years-4.81%
5 Years-
3 Years-
TTM20.38%

EPS CAGR

10 Years0.35%
5 Years-
3 Years-
TTM15%

Return on Capital

10 Years1.33%
5 Years2.52%
3 Years3.59%
Last Year4.43%

GBLI Recent Earnings

Global Indemnity Group, LLC (GBLI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 1/12 qtrs (8%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.57-5.0%
$0.60
Rev
$96M-7.3%
$104M
Q2 2026
Mar 10, 2026
Metric
Actual
Est
EPS
$0.44-48.2%
$0.85
Rev
$85M-15.4%
$100M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$1.08+42.1%
$0.76
Rev
$114M-2.5%
$117M
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$0.71-4.1%
$0.74
Rev
$111M-8.9%
$121M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.57vs $0.60-5.0%
$96Mvs $104M-7.3%
Q2 2026Mar 10, 2026
$0.44vs $0.85-48.2%
$85Mvs $100M-15.4%
Q4 2025Oct 30, 2025
$1.08vs $0.76+42.1%
$114Mvs $117M-2.5%
Q3 2025Aug 6, 2025
$0.71vs $0.74-4.1%
$111Mvs $121M-8.9%
Based on last 12 quarters of dataView full earnings history →

GBLI Peer Comparison

Global Indemnity Group, LLC (GBLI) competitors in Reinsurers and hybrid reinsurance groups — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
HRTG logoHRTGHeritage Insurance Holdings, Inc.Direct Competitor706.24M23.273.683.71%25.99%43.68%0.20
HIHO logoHIHOHighway Holdings LimitedDirect Competitor3.47M0.7932.7217.26%-8.71%-8.95%0.13
PLMR logoPLMRPalomar Holdings, Inc.Direct Competitor2.96B111.7015.5858.16%20.15%21.74%0.01
KFRC logoKFRCKforce Inc.Direct Competitor829.64M45.3923.16-5.43%2.6%27.22%0.56
HCI logoHCIHCI Group, Inc.Product Competitor2.13B163.636.5820.21%32.64%30.81%0.06
NODK logoNODKNI Holdings, Inc.Product Competitor325.86M15.91-31.82-12.35%-1.6%-1.79%
ACGL logoACGLArch Capital Group Ltd.Product Competitor32.48B91.187.8514.27%22.07%19.02%0.11
RLI logoRLIRLI Corp.Product Competitor4.88B53.0912.186.33%20.8%22%0.06

Compare GBLI vs Peers

Global Indemnity Group, LLC (GBLI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HRTG

Most directly comparable listed peer for GBLI.

Scale Benchmark

vs MMC

Larger-name benchmark to compare GBLI against a more recognizable public peer.

Peer Set

Compare Top 5

vs HRTG, HIHO, PLMR, KFRC

GBLI Income Statement

Global Indemnity Group, LLC (GBLI) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue
485.51M498.94M604.47M583.55M678.27M628.53M528.13M441.19M450.1M450.62M
Revenue Growth %
-9.17%2.76%21.15%-3.46%16.23%-7.33%-15.97%-16.46%2.02%2.99%
Medical Costs & Claims
452.94M525.4M483.81M551.81M607.8M595.61M471.77M360.54M228.28M280.85M
Medical Cost Ratio %
93.29%105.3%80.04%94.56%89.61%94.76%89.33%81.72%50.72%62.32%
Gross Profit
32.57M▲ 0%
-26.46M▼ 181.3%
120.67M▲ 555.9%
31.74M▼ 73.7%
70.46M▲ 122.0%
32.92M▼ 53.3%
56.36M▲ 71.2%
80.65M▲ 43.1%
221.82M▲ 175.0%
169.78M▲ 0%
Gross Margin %
6.71%-5.3%19.96%5.44%10.39%5.24%10.67%18.28%49.28%37.68%
Gross Profit Growth %
-55.9%-181.26%555.95%-73.7%122.01%-53.27%71.17%43.1%175.03%-
Operating Expenses
42.62M49.46M38.91M60.85M37.66M30.95M23.38M25.7M188.52M125.87M
OpEx / Revenue %
8.78%9.91%6.44%10.43%5.55%4.92%4.43%5.82%41.88%27.93%
Depreciation & Amortization
6.5M7.02M7.1M7.03M10.41M8.4M6.2M5.76M5.66M4.22M
Combined Ratio %
102.07%115.22%86.47%104.99%95.16%99.69%93.76%87.54%92.6%90.26%
Operating Income
-10.05M▲ 0%
-75.92M▼ 655.5%
81.76M▲ 207.7%
-29.11M▼ 135.6%
32.8M▲ 212.7%
1.97M▼ 94.0%
32.98M▲ 1573.1%
54.96M▲ 66.7%
33.3M▼ 39.4%
43.91M▲ 0%
Operating Margin %
-2.07%-15.22%13.53%-4.99%4.84%0.31%6.24%12.46%7.4%9.74%
Operating Income Growth %
-121.11%-655.47%207.68%-135.61%212.68%-93.99%1573.06%66.65%-39.41%-
EBITDA
-3.54M-68.91M88.86M-22.08M43.22M10.37M39.17M60.72M38.96M48.13M
EBITDA Margin %
-0.73%-13.81%14.7%-3.78%6.37%1.65%7.42%13.76%8.66%10.68%
Interest Expense
16.91M19.69M20.02M15.79M10.48M3M0002.6M
Non-Operating Income
-16.91M-19.69M-20.02M-15.79M-10.48M-3M0000
Pretax Income
-10.05M▲ 0%
-75.92M▼ 655.5%
81.76M▲ 207.7%
-29.11M▼ 135.6%
32.8M▲ 212.7%
1.97M▼ 94.0%
32.98M▲ 1573.1%
54.96M▲ 66.7%
33.3M▼ 39.4%
43.91M▲ 0%
Pretax Margin %
-2.07%-15.22%13.53%-4.99%4.84%0.31%6.24%12.46%7.4%9.74%
Income Tax
-499K-19.23M11.74M-8.11M3.45M2.82M7.55M11.71M7.96M10.34M
Effective Tax Rate %
4.97%25.33%14.36%27.84%10.51%143.13%22.89%21.32%23.92%23.55%
Net Income
-9.55M▲ 0%
-56.7M▼ 493.6%
70.02M▲ 223.5%
-21.01M▼ 130.0%
29.35M▲ 239.7%
-850K▼ 102.9%
25.43M▲ 3091.6%
43.24M▲ 70.0%
25.33M▼ 41.4%
33.57M▲ 0%
Net Margin %
-1.97%-11.36%11.58%-3.6%4.33%-0.14%4.81%9.8%5.63%7.45%
Net Income Growth %
-119.15%-493.61%223.49%-130%239.74%-102.9%3091.65%70.05%-41.41%20.38%
EPS (Diluted)
-0.55▲ 0%
-4.02▼ 630.9%
4.88▲ 221.4%
-1.48▼ 130.3%
1.97▲ 233.1%
-0.09▼ 104.5%
1.83▲ 2153.9%
3.12▲ 70.5%
1.75▼ 43.9%
2.33▲ 0%
EPS Growth %
-119.37%-630.91%221.39%-130.33%233.11%-104.52%2153.87%70.49%-43.91%15%
EPS (Basic)
-0.55-4.024.93-1.482.00-0.091.843.141.75-
Diluted Shares Outstanding
17.31M14.09M14.33M14.29M14.66M14.48M13.67M13.71M14.26M14.4M

GBLI Balance Sheet

Global Indemnity Group, LLC (GBLI) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets
2B1.96B2.08B1.9B2.01B1.8B1.73B1.73B1.72B1.68T
Asset Growth %
1.46%-2.07%5.9%-8.24%5.66%-10.56%-3.93%0.1%-0.61%97942.47%
Total Investment Assets
1.46B1.41B2.77B2.48B2.5B2.51B1.04B1.42B1.38B4M
Long-Term Investments
1.38B1.36B1.52B1.29B1.3B1.27B38.24M239.83M288.05M928.11M
Short-Term Investments
1.38B1.24B1.25B1.19B1.2B1.25B1B1.18B1.09B0
Total Current Assets
158.8M1.55B1.51B1.46B1.51B1.54B38.04M1.35B1.29B34.83B
Cash & Equivalents
74.41M99.5M44.27M67.36M78.28M38.85M38.04M17.01M65.54M65.54M
Receivables
087.68M212.96M198.14M228.31M254.46M186.46M142.82M132.18M489.94M
Other Current Assets
0450.75M324.74M356.32M385.09M425.99M-1.05B00-71.41M
Goodwill & Intangibles
29.07M28.54M28.01M27.48M25.66M19.63M19.28M18.92M62.85M21.65B
Goodwill
6.52M6.52M6.52M6.52M5.4M4.82M4.82M4.82M4.82M4.82B
Intangible Assets
22.55M22.02M21.49M20.96M20.26M14.81M14.46M14.1M58.03M16.73B
PP&E (Net)
01.34B1.51B1.28B16.05M11.74M9.71M9.29M8.17M7.81B
Other Assets
-1.38B-1.39B-1.54B-1.32B-37.33M-47.1M718.97M116.28M52.07M0
Total Liabilities
1.28B1.33B1.35B1.19B1.31B1.17B1.08B1.04B1.01B976.01B
Total Debt
294.71M288.56M296.64M149.24M145.51M15.7M12.73M10.37M8.33M0
Net Debt
220.3M189.07M252.37M81.88M67.23M-23.14M-25.3M-6.64M-57.21M-65.54M
Long-Term Debt
294.71M288.56M296.64M126.29M126.43M00000
Short-Term Debt
0000000000
Total Current Liabilities
10.85M695.02M31.08M34.27M37.33M47.1M2.64M991.98M956.37M196M
Accounts Payable
10.85M14.99M20.4M8.94M35.34M17.24M2.64M8.18M1.86M0
Deferred Revenue
00034.27M047.1M00182.73M0
Other Current Liabilities
-4.05M-14.99M9.82M-13.61M1.2M-17.31M-1.59M983.8M750.19M196M
Deferred Taxes
1000K1000K001000K1000K0000
Other Liabilities
981.76M1.04B1.02B1B-145.51M1.11B1.07B39.75M49.47M975.81B
Total Equity
718.39M▲ 0%
629.06M▼ 12.4%
726.81M▲ 15.5%
718.32M▼ 1.2%
706.62M▼ 1.6%
626.23M▼ 11.4%
648.75M▲ 3.6%
689.15M▲ 6.2%
706.59M▲ 2.5%
704.11B▲ 0%
Equity Growth %
-9.97%-12.44%15.54%-1.17%-1.63%-11.38%3.6%6.23%2.53%102392.16%
Shareholders Equity
718.39M629.06M726.81M718.32M706.62M626.23M648.75M689.15M706.59M704.11B
Minority Interest
0000000000
Retained Earnings
275.84M215.13M270.77M234.97M249.3M233.47M244.99M268.67M273.56M272.68B
Common Stock
2K2K2K000000-32.69B
Accumulated OCI
8.98M-21.23M17.61M34.31M6.4M-43.06M-22.86M-10.41M-4M-6.6B
Return on Equity (ROE)
-1.26%-8.42%10.33%-2.91%4.12%-0.13%3.99%6.46%3.63%0.02%
Return on Assets (ROA)
-0.48%-2.86%3.47%-1.06%1.5%-0.04%1.44%2.5%1.47%0.01%
Equity / Assets
35.89%32.09%35.01%37.71%35.11%34.78%37.51%39.81%41.06%41.91%
Debt / Equity
0.41x0.46x0.41x0.21x0.21x0.03x0.02x0.02x0.01x0.00x
Book Value per Share
41.5044.6550.7050.2648.1943.2447.4750.2849.5548879.56
Tangible BV per Share
39.8342.6248.7548.3446.4441.8946.0648.9045.1447383.62

GBLI Cash Flow Statement

Global Indemnity Group, LLC (GBLI) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-23.65M42.07M32.38M32.67M90.8M44.24M42.89M38.84M9.06M6.67M
Operating CF Growth %
3.06%277.88%-23.04%0.91%177.93%-51.28%-3.05%-9.45%-76.66%-160.26%
Operating CF / Revenue %
-4.87%8.43%5.36%5.6%13.39%7.04%8.12%8.8%2.01%1.48%
Net Income
-9.55M-56.7M70.02M-21.01M29.35M-850K25.43M43.24M25.33M33.57M
Depreciation & Amortization
6.5M7.02M7.1M7.03M10.41M8.4M6.2M-9.89M17.37M3.39M
Stock-Based Compensation
3.74M3.45M4.22M6.77M2.35M3.9M3.49M001.72M
Deferred Taxes
-1.02M-19.55M11.78M-8.27M3.4M2.4M5.33M11.3M751K2.08M
Other Non-Cash Items
1.81M23.1M-30.19M31.24M-35.14M20.97M-7.01M3.73M10.35M2.66M
Working Capital Changes
-25.14M84.75M-30.55M16.9M80.42M9.43M9.46M-9.54M-44.74M-36.76M
Cash from Investing
-24.21M5.32M-80.24M174.59M-64.52M80.13M-16.33M-39.51M59.91M-6.93M
Capital Expenditures
-1.46M-9.45M-24.12M-25.72M000000
Acquisitions
-6.96M23.55M3.47M-56.09M-52.92M107.92M00-1.3M19.25K
Purchase of Investments
-1.11B-406.79M-1.5B-1.26B-1.25B-1.18B-448.58M-1.14B-25.02M-1.82B
Sale/Maturity of Investments
1.1B388.56M1.42B1.5B1.21B1.12B432.25M1.1B2.57B1.81B
Other Investing
1.46M9.45M24.12M25.72M28M30M00-2.49B-713.15K
Cash from Financing
47.16M-22.31M-7.36M-184.17M-15.36M-163.8M-27.36M-20.36M-20.44M-15.34M
Dividends Paid
0-14.03M-14.22M-14.38M-14.87M-14.81M-14.69M-19.83M-20.44M-15.51M
Share Repurchases
-84.17M-1.87M-947K-153K-490K-22.34M-12.68M-529K00
Stock Issued
000003.34M0000
Debt Issuance (Net)
1000K-1000K1000K-1000K0-1000K0000
Other Financing
-4.25M00-100M00000165.04K
Net Change in Cash
-696K▲ 0%
25.08M▲ 3703.9%
-55.23M▼ 320.2%
23.09M▲ 141.8%
10.92M▼ 52.7%
-39.43M▼ 461.1%
-809K▲ 97.9%
-21.03M▼ 2499.3%
48.53M▲ 330.8%
-46.32M▲ 0%
Exchange Rate Effect
000000000-30.71M
Cash at Beginning
75.11M74.41M99.5M44.27M67.36M78.28M38.85M38.04M17.01M65.54M
Cash at End
74.41M99.5M44.27M67.36M78.28M38.85M38.04M17.01M65.54M34.83M
Free Cash Flow
-25.11M▲ 0%
32.62M▲ 229.9%
8.26M▼ 74.7%
6.95M▼ 15.8%
90.8M▲ 1206.5%
44.24M▼ 51.3%
42.89M▼ 3.1%
38.84M▼ 9.4%
9.06M▼ 76.7%
6.67M▲ 0%
FCF Growth %
61.56%229.87%-74.69%-15.82%1206.46%-51.28%-3.05%-9.45%-76.66%-65.36%
FCF Margin %
-5.17%6.54%1.37%1.19%13.39%7.04%8.12%8.8%2.01%1.48%
FCF per Share
-1.452.310.580.496.193.053.142.830.640.46

GBLI Key Ratios

Global Indemnity Group, LLC (GBLI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio
102.07%115.22%86.47%104.99%95.16%99.69%93.76%87.54%92.6%90.26%
Medical Cost Ratio
93.29%105.3%80.04%94.56%89.61%94.76%89.33%81.72%50.72%62.32%
Return on Equity (ROE)
-1.26%-8.42%10.33%-2.91%4.12%-0.13%3.99%6.46%3.63%0.02%
Return on Assets (ROA)
-0.48%-2.86%3.47%-1.06%1.5%-0.04%1.44%2.5%1.47%0.01%
Equity / Assets
35.89%32.09%35.01%37.71%35.11%34.78%37.51%39.81%41.06%41.91%
Book Value / Share
41.544.6550.750.2648.1943.2447.4750.2849.5548.88K
Debt / Equity
0.41x0.46x0.41x0.21x0.21x0.03x0.02x0.02x0.01x0.00x
Revenue Growth
-9.17%2.76%21.15%-3.46%16.23%-7.33%-15.97%-16.46%2.02%2.99%
Related:GBLI Dividend History·GBLI Revenue History·GBLI Price History·GBLI P/E History·GBLI Financial Ratios·GBLI Institutional Holders

GBLI SEC Filings & Documents

Global Indemnity Group, LLC (GBLI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Mar 20, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 10, 2026·SEC

FY 2025

Mar 11, 2025·SEC

FY 2024

Mar 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 6, 2025·SEC

GBLI Frequently Asked Questions

Global Indemnity Group, LLC (GBLI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Global Indemnity Group, LLC (GBLI) grew revenue by 2.0% over the past year. Growth has been modest.

Yes, Global Indemnity Group, LLC (GBLI) is profitable, generating $33.6M in net income for fiscal year 2025 (5.6% net margin).

Dividend & Returns

Yes, Global Indemnity Group, LLC (GBLI) pays a dividend with a yield of 5.54%. This makes it attractive for income-focused investors.

Global Indemnity Group, LLC (GBLI) has a return on equity (ROE) of 3.6%. This is below average, suggesting room for improvement.

Industry Metrics

Global Indemnity Group, LLC (GBLI) has a combined ratio of 92.6%. A ratio below 100% indicates underwriting profitability.

What if you invested $1,000 in GBLI back in 2002?

Total return calculator · dividends reinvested · 24+ years of data

See returns →

How much would $100/month in GBLI be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →